Evidence map›Paper›PMID 42326975›Full record

ArticlePathology oncology research : POR2026

Takako Kihara, Jiayin Yuan, Takashi Yamasaki, Makoto Yoshida, Mizuka Ohkouchi, Yuka Nakaya-Hashikura, Neinei Kimura, Kanae Hyodo, Chisato Ohe, Seiichi Hirota

Abstract read
In one paragraph

Article in Pathology oncology research : POR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Takako KiharaDepartment of Diagnostic Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo, Japan.
Jiayin YuanDepartment of Pathology, First People's Hospital of Foshan, Foshan, Guangdong, China.
Takashi YamasakiDepartment of Diagnostic Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo, Japan.
Makoto YoshidaDepartment of Diagnostic Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo, Japan.
Mizuka OhkouchiDepartment of Diagnostic Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo, Japan.
Yuka Nakaya-HashikuraDepartment of Diagnostic Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo, Japan.
Neinei KimuraDepartment of Diagnostic Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo, Japan.
Kanae HyodoDepartment of Diagnostic Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo, Japan.
Chisato OheDepartment of Diagnostic Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo, Japan.
Seiichi HirotaDepartment of Diagnostic Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Small intestinal gastrointestinal stromal tumors (SI-GISTs) have a higher risk of distant metastasis and recurrence than gastric GISTs (G-GISTs). However, the underlying mechanisms contributing to the poor prognosis of SI-GISTs remain elusive. Previous research has demonstrated that SI-GISTs exhibit elevated expression of Methods: To elucidate the relationship between Results: In GIST cells, Conclusion: Elevated

Indexed as

Biomarkers, TumorConnexin 43Gastrointestinal NeoplasmsGastrointestinal Stromal TumorsLiver NeoplasmsAnimalsCell MovementCell ProliferationFemaleHumansMaleMiceMice, NudePrognosisTumor Cells, CulturedBiomarkers, TumorConnexin 43GJA1 protein, humanConnexin 43gastrointestinal stromal tumorinteraction with vascular endothelial cellsinvasionliver metastasis

Identifiers

PMID42326975
PMCPMC13275379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.